Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover study.
Niels B DalsgaardLærke S GasbjergLaura Smidt HansenDennis S NielsenTorben S RasmussenFilip K Krag KnopPublished in: Endocrine connections (2024)
In patients with metformin-treated T2D, 14 days of treatment with acarbose showed only minor effects on GM as seen in increased relative abundances of Klebsiella spp. and Escherichia coli.